Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: Attenuation of established arthritis, selective depletion of Cd4+ T cells, and CD2 down-modulation

Clinical and Experimental Immunology

Volumn 110, Issue 1, 1997, Pages 63-71

  Hoffmann, J C ^a,b   Herklotz, C ^a   Zeidler, H ^a   Bayer, B ^a   Westermann, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Adjuvant arthritis; CD2; CD4 subsets; Lymphatic organs; Therapy

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 34; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HYBRIDOMA; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030804590     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.488-ce1385.x     Document Type: Article

References (42)

1. Crofford LJ, Wilder RL. Arthritis and autoimmunity in animals. In: McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions, 12th edn. Philadelphia: Lea & Febiger, 1993:525-41.
2. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-89.
3. Panayi GS, Lanchhury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35:729-35.
4. Pelegri C, Paz Morante M, Castellote C, Castell M, Franch A. Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25. Cell Immunol 1995; 165:177-82.
5. Yoshino S, Schlipkoter E, Kinne R, Hunig T, Emmrich F. Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur J Immunol 1990; 20:2805-8.
6. Pelegri C, Morante MP, Castellote C, Franch A, Castell M. Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis. Clin Exp Immunol 1996; 103:273-8.
7. Epstein WV. Expectation bias in rheumatoid arthritis clinical trials: the anti-CD4 monoclonal antibody experience. Arthritis Rheum 1996; 39:1773-80.
8. Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992; 35:603-10.
9. Quayle AJ, Chomarat P, Miossec P, Kjeldsen Kragh J, Forre O, Natvig JB. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993; 38:75-82.
10. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
11. Chavin KD, Qin L, Yon R, Lin J, Yagita H, Bromberg JS. Anti-CD2 mAbs suppress cytotoxic lymphocyte activity by the generation of Th2 suppressor cells and receptor blockade. J Immunol 1994; 152:3729-39.
12. Hirahara H, Tsuchida M, Watanabe T et al. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 1995; 59:85-90.
13. Gückel B, Berek C, Lutz M, Allevogt P, Schirrmacher V, Kyewski BA. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 1991; 174:957-67.
14. Kato K, Koyanagi M, Okada H et al. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 1992; 176:1241-9.
15. van der Merwe PA, McPherson DC, Brown MH et al. The NH2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2. Eur J Immunol 1993; 23:1373-7.
16. Arvieux J, Willis AC, Williams AF. MRC OX-45 antigen: a leucocyte/ endothelium rat membrane glycoprotein of 45,000 molecular weight. Mol Immunol 1986; 23:983-90.
17. Davis SJ, van der Merwe PA. The structure and ligand interactions of CD2: implications for T-cell functions. Immunol Today 1996; 17:177-87.
18. Arvieux J, Jefferies WA, Paterson DJ, Williams AF, Green JR. Monoclonal antibodies against a rat leucocyte antigen block antigen-induced T-cell responses via an effect on accessory cells. Immunology 1986; 58:337-42.
19. Seaman WE, Eriksson E, Dobrow R, Imboden JB. Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells. Proc Natl Acad Sci USA 1987; 84:4239-43.
20. + T cells and macrophages. Immunology 1993; 78:50-57.
21. 4+ T cells. J Exp Med 1994; 180:2125-35.
22. Gollob JA, Li J, Reinherz EL, Ritz J. CD2 regulates responsiveness of activated T cells to interleukin 12. J Exp Med 1995; 182:721-31.
23. Killeen N, Stuart SG, Littman DR. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 1992; 11:4329-36.
24. + T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991; 123:37-64.
25. Peacock DJ, Banquerigo ML, Brahn E. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992; 175:1135-8.
26. Westermann J, Nagahori Y, Walter S, Heerwagen C, Miyasaka M, Pabst R. B and T lymphocyte subsets enter peripheral lymph nodes and Peyer's patches without preference in vivo: no correlation occurs between their localization in different types of high endothelial venules and the expression of CD44, VLA-4, LFA-1, ICAM-1, CD2 or L-selectin. Eur J Immunol 1994; 24:2312-6.
27. Westermann J, Walter S, Nagahori Y, Heerwagen C, Miyasaka M, Pabst R. Blood leucocyte subsets of the rat: expression of adhesion molecules and localization within high endothelial venules. Scand J Immunol 1996; 43:297-303.
28. Westermann J, Persin S, Matyas J, van der Meide P, Pabst R. Migration of so-called naive and memory T lymphocytes from blood to lymph in the rat. The influence of IFN-gamma on the circulation pattern. J Immunol 1994; 152:1744-50.
29. Westermann J, Ronneberg S, Fritz FJ, Pabst R. Proliferation of macrophage subpopulations in the adult rat: comparison of various lymphoid organs. J Leukoc Biol 1989; 46:263-9.
30. Westermann J, Smith T, Peters U et al. Both activated and non-activated leukocytes from the periphery continuously enter the thymic medulla of adult rats: phenotypes, sources and magnitude of traffic. Eur J Immunol 1996; 26:1866-74.
31. Telerman A, Amson RB, Romasco F, Wybran J, Galand P, Mosselmans R. Internalization of human T lymphocyte receptors. Eur J Immunol 1987; 17:991-7.
32. Lin J, Yon RW, Chavin KD et al. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2. Transplantation 1995; 59:1162-71.
33. Jung S, Toyka K, Hartung HP. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Eur J Immunol 1995; 25:1391-8.
34. Barlow AK, Like AA. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat. Am J Pathol 1992; 141:1043-51.
35. Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 1996; 87:404-11.
36. Wesselborg S, Prufer U, Wild M, Schraven B, Meuer SC, Kabelitz D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 1993; 23:2707-10.
37. + T cells is induced by some combinations of anti-CD2 mAb. J Immunol 1993; 151:3547-56.
38. Westermann J, Pabst R. How organ-specific is the migration of 'naive' and 'memory' T lymphocytes? Immunol Today 1996; 17:278-82.
39. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511-8.
40. Chu CQ, Londei M. Induction of Th2 cytokines and control of collage-induced arthritis by nondepleting anti-CD4 Abs. J Immunol 1996; 157:2685-9.
41. Clark SJ, Law DA, Paterson DJ, Puklavec M, Williams AF. Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies. J Exp Med 1988; 167:1861-72.
42. Bromberg JS, Chavin KD, Altevogt P et al. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation 1991; 51:219-25.